| Issue |
BIO Web Conf.
Volume 148, 2024
International Conference of Biological, Environment, Agriculture, and Food (ICoBEAF 2024)
|
|
|---|---|---|
| Article Number | 04003 | |
| Number of page(s) | 11 | |
| Section | Food | |
| DOI | https://doi.org/10.1051/bioconf/202414804003 | |
| Published online | 09 January 2025 | |
Trends in drug repurposing for chronic hepatitis-B infection: Bibliometric-based approach 1990-2024
1 Faculty of Pharmacy, Universitas Ahmad Dahlan, Yogyakarta, Daerah Istimewa Yogyakarta, Indonesia
2 Departement of Pharmacy, Universitas Muhammadiyah Mataram, Mataram, West Nusa Tenggara, Indonesia
3 Research Center for Computing, Research Organization for Electronics and Informatics, National Research and Innovation Agency (BRIN), Cibinong Science Center, Cibinong, West Java, Indonesia
4 University Institute of Pharma Sciences, Chandigarh University, Gharuan, Mohali, India.
5 University Centre for Research and Development, Chandigarh University, Gharuan, India.
6 Department of Chemistry and Biochemistry, University of California, Los Angeles, USA
7 Faculty of Nursing and Health Sciences, Universitas Muhammadiyah Semarang, Semarang, Central Java, Indonesia.
8 School of Nursing, College of Nursing, Taipei Medical University, Taipei, Taiwan
* Corresponding author: lalu.irham@pharm.uad.ac.id
Chronic hepatitis B (CHB) infection is still a world problem today, especially in the developing countries. Until now, treatment related to CHB is still being continuously pursued using a variety of the latest approaches. One of today’s scientific efforts that can accelerate drug discovery for CHB is by using the concept of drug repurposing or drug repositioning. Our research drug trends using a drug repurposing approach for CHB from 1990-2024. To find the related data, we used some words include “drug repurposing, drug repositioning, drug retasking, drug re- profiling, drug recycling, drug redirection and therapeutic switching”. The study trends we analysed were from 1990-2024, with details of 259 documents originating from 189 journals. The types of articles nominated included 134 original articles and 105 documents review articles. The most dominant drug repurposing study trend in 2021 (46 documents), subsequently followed by 2022 (39 documents), 2020 (33 documents) and 2023 (24 documents). The countries with the highest level of paper citations related drug repurposing are the USA and Germany. our findings show a trend in studies related to the reuse of drugs for CHB in the latest of current decade showing serious focus given by scientists who are concerned about Hepatitis B
© The Authors, published by EDP Sciences, 2024
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.